Market Overview

UPDATE: Gilead Posts Upbeat Q4 Results

Share:
Related GILD
Does This Data Show 2015 Is Finally The Year To 'Sell In May?'
What Does The Johnson & Johnson/Achillion Deal Mean For HCV Competitors?
Gilead Hangs Tough Despite Challenges In Hep C Market (Investor's Business Daily)

Gilead Sciences (NASDAQ: GILD) reported a 15% rise in its fourth-quarter earnings.

Gilead's quarterly profit surged to $762.5 million, or $0.47 per share, from $665.1 million, or $0.43 per share, in the year-ago period. Excluding one-time items, its adjusted earnings came in at $0.50 per share.

Its revenue climbed 18% to $2.59 billion. However, analysts were expecting earnings of $0.48 per share on revenue of $2.43 billion.

Its operating margin climbed to 42.8% from 39.4%

Gilead shares gained 0.76% to $39.89 in after-hours trading.

Posted-In: profitEarnings News

 

Related Articles (GILD)

Around the Web, We're Loving...

Get Benzinga's Newsletters